4583 Chiome Bioscience Inc.カイオム・バイオサイエンスTSE Growth / Pharmaceuticals
0 posts
Chiome Bioscience Inc. (4583) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Chiome Bioscience Inc. (4583) Stock Price History
Chiome Bioscience Inc. closed at ¥75.0 on Nov 20, 2026, −14.8% over 1 month, −40.0% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥85,227 today (−14.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −14.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥75.0 | −3 | −3.85% |
| Nov 19 (Thu) | ¥78.0 | +0 | +0.00% |
| Nov 18 (Wed) | ¥78.0 | +3 | +4.00% |
| Nov 17 (Tue) | ¥75.0 | −4 | −5.06% |
| Nov 16 (Mon) | ¥79.0 | +2 | +2.60% |
| Nov 13 (Fri) | ¥77.0 | +1 | +1.32% |
| Nov 12 (Thu) | ¥76.0 | −1 | −1.30% |
| Nov 11 (Wed) | ¥77.0 | −5 | −6.10% |
| Nov 10 (Tue) | ¥82.0 | +4 | +5.13% |
| Nov 9 (Mon) | ¥78.0 | +4 | +5.41% |
If you had invested ¥100,000 3 months ago, it would be worth ¥89,286 today (−10.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −10.7%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥75.0 | −3 | −3.85% |
| Nov 19 (Thu) | ¥78.0 | +0 | +0.00% |
| Nov 18 (Wed) | ¥78.0 | +3 | +4.00% |
| Nov 17 (Tue) | ¥75.0 | −4 | −5.06% |
| Nov 16 (Mon) | ¥79.0 | +2 | +2.60% |
| Nov 13 (Fri) | ¥77.0 | +1 | +1.32% |
| Nov 12 (Thu) | ¥76.0 | −1 | −1.30% |
| Nov 11 (Wed) | ¥77.0 | −5 | −6.10% |
| Nov 10 (Tue) | ¥82.0 | +4 | +5.13% |
| Nov 9 (Mon) | ¥78.0 | +4 | +5.41% |
If you had invested ¥100,000 6 months ago, it would be worth ¥85,227 today (−14.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −14.8%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥75.0 | −15.7% |
| Oct 2026 | ¥89.0 | −17.6% |
| Sep 2026 | ¥108 | +28.6% |
| Aug 2026 | ¥84.0 | +21.7% |
| Jul 2026 | ¥69.0 | −12.7% |
| Jun 2026 | ¥79.0 | −6.0% |
| May 2026 | ¥84.0 | −16.0% |
If you had invested ¥100,000 1 year ago, it would be worth ¥60,000 today (−40.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −40.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥75.0 | −15.7% |
| Oct 2026 | ¥89.0 | −17.6% |
| Sep 2026 | ¥108 | +28.6% |
| Aug 2026 | ¥84.0 | +21.7% |
| Jul 2026 | ¥69.0 | −12.7% |
| Jun 2026 | ¥79.0 | −6.0% |
| May 2026 | ¥84.0 | −16.0% |
| Apr 2026 | ¥100 | −2.9% |
| Mar 2026 | ¥103 | −8.0% |
| Feb 2026 | ¥112 | +0.0% |
| Jan 2026 | ¥112 | +4.7% |
| Dec 2025 | ¥107 | −15.1% |
| Nov 2025 | ¥126 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥55,147 today (−44.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −44.9%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥75.0 | −29.9% |
| 2025 | ¥107 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥36,585 today (−63.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +101.3%, while this stock moved −63.4%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥75.0 | −29.9% |
| 2025 | ¥107 | ― |
If you had invested ¥100,000 in Jan 2012, it would be worth ¥26,667 today (−73.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +459.7%, while this stock moved −73.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥75.0 | −29.9% |
| 2025 | ¥107 | −60.2% |
| 2024 | ¥269 | +99.3% |
| 2023 | ¥135 | −24.2% |
| 2022 | ¥178 | −8.7% |
| 2021 | ¥195 | +4.8% |
| 2020 | ¥186 | −7.9% |
| 2019 | ¥202 | +7.4% |
| 2018 | ¥188 | −46.1% |
| 2017 | ¥349 | −24.5% |
| 2016 | ¥462 | −26.1% |
| 2015 | ¥625 | −55.0% |
| 2014 | ¥1,388 | −13.9% |
| 2013 | ¥1,613 | −22.3% |
| 2012 | ¥2,075 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2012). Please check the latest prices before trading.
Chiome Bioscience Inc. (4583) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Chiome Bioscience Inc. (4583)
Business overview
The company is a biotech working on antibody drug discovery. Using its own technology platform and other antibody and protein technologies, it researches and develops antibody drugs for diseases where treatment satisfaction is still low, such as pancreatic cancer, lung cancer, Alzheimer's disease and ALS.
Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 4.08x | Above the sector median of 1.86x (No. 62 from the lowest) |
|---|---|---|
| Market cap | ¥6.1 bn | No. 56 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥126 | 2025/11/28 |
|---|---|---|
| 52-week low | ¥66 | 6/25 |
| Current position | 15.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥75) |
| Year to date | -29.9% | No. 53 of 77 in the sector (best first) |
| 1 year | -40.0% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 2 times | Latest: 10/21 (No. 49) |
|---|---|---|
| Top 50 losers | 1 times | Latest: 11/11 (No. 47) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/16 16:00ヒト化DLK-1抗体・FGFR4阻害剤併用に関する米国における特許査定についてのお知らせ
- 11/10 16:002026年12月期 第3四半期決算短信〔日本基準〕(非連結)
- 11/10 16:00営業外費用の計上に関するお知らせ
- 11/10 16:00決算補足資料 2026年12月期 第3四半期
- 11/09 16:30(開示事項の経過)アルフェナックス バイオロジクス株式会社への共同出資に関する株式引受契約締結のお知らせ
- 09/25 12:00ヒト化DLK-1抗体・レンバチニブ併用に関する米国における特許査定についてのお知らせ
Filings from the past 12 months (6).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the Chiome Bioscience Inc. board
More Japanese stocks in English
- Kidswell Bio Corporation4584
- Medrx Co.,Ltd.4586
- PeptiDream Inc.4587
- Oncolys BioPharma Inc.4588
- PLAN DO Co.,Ltd.458A
- RIBOMIC Inc.4591
- SanBio Company Limited4592
- HEALIOS K.K.4593
- BrightPath Biotherapeutics Co.,Ltd.4594
- MIZUHO MEDY CO.,LTD.4595
- Kubota Pharmaceutical Holdings Co.,Ltd.4596
- Solasia Pharma K.K.4597